Rchr
J-GLOBAL ID:200901066590514879   Update date: Jan. 30, 2024

Naoki Mori

モリ ナオキ | Naoki Mori
Affiliation and department:
Job title: Professor
Homepage URL  (1): https://naokimori50.wixsite.com/mysite
Research field  (3): Cell biology ,  Hematology and oncology ,  Virology
Research keywords  (11): 細胞浸潤 ,  分子標的療法 ,  アポトーシス ,  転写因子 ,  成人T細胞白血病/リンパ腫 ,  HTLV-1 ,  Cell invasion ,  Molecular targetted therapy ,  Apoptosis ,  Transcription factor ,  ATLL
Research theme for competitive and other funds  (12):
  • 2013 - 2016 IkappaB-zeta, a regulator of NF-kappaB, contributes to the pathogenesis of ATL
  • 2009 - 2011 ATF3による成人T細胞白血病細胞運命制御
  • 2008 - 2009 HTLV-1の発がん機構における遺伝子編集酵素AIDの関与
  • 2007 - 2008 Expression of caveolin-1 in adult T-cell leukemia
  • 2004 - 2006 Multiple cancer of the head and neck -viral infection and mismatch repair gene variation-
Show all
Papers (74):
  • Chie Ishikawa, Naoki Mori. FX1, a BCL6 inhibitor, reactivates BCL6 target genes and suppresses HTLV-1-infected T cells. Investigational new drugs. 2021
  • Chie Ishikawa, Naoki Mori. The antipsychotic drug pimozide is effective against human T-cell leukemia virus type 1-infected T cells. European journal of pharmacology. 2021. 908. 174373-174373
  • Chie Ishikawa, Masachika Senba, Naoki Mori. Importin β1 regulates cell growth and survival during adult T cell leukemia/lymphoma therapy. Investigational new drugs. 2020. 39. 2. 317-329
  • Chie Ishikawa, Naoki Mori. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. Investigational new drugs. 2020. 39. 1. 111-121
  • Chie Ishikawa, Naoki Mori. The role of CUDC-907, a dual phosphoinositide-3 kinase and histone deacetylase inhibitor, in inhibiting proliferation of adult T-cell leukemia. European journal of haematology. 2020. 105. 6. 763-772
more...
MISC (57):
  • MALT1 as a novel therapeutic target for adult T-cell leukemia. 2019. S161
  • 森直樹, 石川千恵. インポーチンβ1はKSHV感染原発性体腔液性リンパ腫の細胞増殖と生存を司る. 第67回日本ウイルス学会学術集会. 2019. P-DN-22
  • Naoki Mori, Chie Ishikawa. CUDC-907, a novel dual PI3K and HDAC inhibitor, blocks multiple signaling pathways in primary effusion lymphoma. 2019. 187
  • 森直樹, 石川千恵. 成人 T 細胞白血病の新規治療標的 MALT1. 第6回日本HTLV-1学会学術集会プログラム集. 2019. 80
  • Naoki Mori, Chie Ishikawa. Evaluation of artesunate for the treatment of adult T-cell leukemia. 臨床血液. 2018. 59. 9. 1720-1720
more...
Books (11):
  • Challenge to the threat of invisible transmission: Global health security for the control of emerging infectious disease outbreaks
    Nova Science Publishers 2016
  • Mechanisms of cancer formation under interplay between host immunity and human papillomavirus (HPV) infection
    Nova Science Publishers 2016
  • Challenge to the threat of invisible transmission: global health security for the control of emerging infectious diseases outbreaks
    2016
  • Pathogenesis of Kaposi sarcoma associated with human herpesvirus-8 infection
    2012
  • Pathogenesis of Kaposi sarcoma associated with human herpesvirus-8 infection
    2012
more...
Work history (2):
  • 2002/04/01 - - , 琉球大学 医学研究科 教授
  • 2002/04/01 - - , University of the Ryukyus, Graduate School of Medicine, Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page